je.st
news
Tag: copaxone
Teva shares slide on generic Copaxone fears
2015-04-20 00:21:19| Biotech - Topix.net
Teva Pharmaceutical Industries shares slid five percent on Sunday after U.S. regulators approved a generic version of its top-selling multiple sclerosis drug and amid reports it was mulling a bid for rival Mylan. Teva's Tel Aviv shares fell to 249.80 shekels late on Sunday, the first day of trading since both news hit the market on Thursday after Israel's market closed for the weekend.
Tags: shares
slide
generic
fears
FDA accepts Mylan's ANDA filing for generic Copaxone 40 mg/mL
2014-08-29 14:50:24| Biotech - Topix.net
Mylan Inc. today announced that its abbreviated new drug application for a three times per week Glatiramer Acetate Injection 40 mg/mL has been accepted for filing by the U.S. Food and Drug Administration .
Tags: filing
generic
accepts
anda
FDA's Looming Decision On Generic Copaxone From Teva Reveals Drug Approval Woes
2014-07-07 13:57:56| Biotech - Topix.net
A year ago, the Food and Drug Administration quietly posted a public notice that it wanted to hire an independent lab to test a generic drug that it had already approved.
Tags: decision
drug
approval
generic
Supreme Court denies Teva stay in Copaxone patent fight
2014-04-21 18:48:29| Biotech - Topix.net
U.S. Supreme Court Chief Justice John Roberts on Friday denied a request by Teva Pharmaceutical Industries Ltd to stay a lower-court ruling in a patent case that favored the developers of generic versions of Teva's top-selling multiple sclerosis drug.
UPDATE 1-Teva asks U.S. Supreme court to stay ruling in Copaxone case
2014-04-07 22:34:19| Biotech - Topix.net
Teva Pharmaceutical Industries Ltd asked the U.S. Supreme Court on Monday to stop a lower court ruling from going into effect while the justices consider an appeal in a patent fight over Teva's top-selling multiple sclerosis drug Copaxone.